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Abstract
Dentistry science is a new specialty in veterinary medicine that has been 
 growing in recent years, accompanied by the development of professionals who 
seek to improve the quality of life of pets. Cases related to problems in the oral 
cavity have gained significant importance in the medical clinic of professionals 
who treat small animals. Due to lack of professional knowledge or due to animal 
behavioral problems, such as aggressiveness, the anamnesis of the oral cavity is not 
performed most of the time, which ends up delaying the diagnosis of the pathology. 
In addition, an animal with a problem in the oral cavity may take years to show 
signs of the disease. In general, animals have an oral microbiota composed of vari-
ous species of fungi, which, under specific conditions, can change from saprophytes 
to pathogens, compromising their health. Thus, the pre-knowledge of potentially 
pathogenic yeasts belonging to oral microbiota of dogs and their susceptibility 
profile compared to the main drugs used in antifungal therapy, is of fundamental 
importance as it ensures a clinical auxiliary support for the diagnosis and treatment 
of most diseases of the oral cavity.
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1. Introduction
Fungi are eukaryotic, heterotrophic organisms, multinucleated like molds, or 
only with one nucleus, like yeasts. These organisms can be unicellular, or multicel-
lular, which we call mycelium. Yeasts are unicellular and do not present, in general, 
morphological differences. The cells are rounded, ovoid or elongated, but some 
yeast under special conditions may have successive sprouts in a chain, which we call 
pseudomycelium [1].
The classification of fungi is based on morphological, reproductive and 
physiological characteristics. The taxonomy of fungi is still varied, but we 
can classify them in the Kingdom Fungi in the six phylas: Basidyomycota, 
Ascomycota, Glomeromycota, Chytridiomycota, Blastocladiomycota and 
Neocallimastigomycota [2, 3].
Approximately 200 out of a total of 100,000 species of yeast are considered 
pathogenic. Of these pathogenic species, 50 of them are regularly associated with 
mycoses. Yeasts are the ones that cause the greatest number of mycoses, both in man 
and in animals and we highlight the genera Candida, Cryptococcus, Malassezia and 
Trichosporon [3].
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These yeasts can be assexual (anascoporogenous), or sexual (ascoporogenous 
or basidioporogenous). In general, they are considered opportunists “waiting” for 
their “opportunity”, that is, the drop in the immunity of man and animals, thus 
causing a case of ringworm.
Among domestic animals, the ones that have the closest proximity to people 
are dogs. Canis lupus familiaris is believed to have emerged approximately 
130,000 years ago, from the domestication of the gray wolf. Crossbreeding 
and selection of characteristics gave rise to different breeds, including Poodle, 
Yorkshire, Terrier and Labrador Retriever, but mixed breed animals are prevalent in 
homes around the world (Figure 1) [4].
In addition to being mere companions in people’s homes dogs have established 
themselves with essential functions such as security and hunting. These dogs have 
gained these and other noble functions and thus brought them even closer to human 
beings in places and situations that would otherwise be dispensed with. Today they 
also act as guides for the visually impaired, accompanying people to the hospital, 
monitoring blood glucose levels for diabetic people and even detecting pathogens in 
hospital environments [5].
These new functions, with consequently greater proximity between dogs and 
people, also result in a possible greater exchange of microorganisms between 
these beings, including yeasts. Among these fungi, the most present in the oral 
mucosa of dogs are the genera Malassezia and Candida and found less the genus 
Cryptococcus [6].
In the field of public health, these microorganisms have in common the ability 
to cause disease in both animals and people, and therefore this possible increase 
in the sharing of microbiota between these beings must be monitored by health 
specialists.
It is important to emphasize that the exchange of microorganisms occurs in both 
directions, and that the health of the animals must also be considered in these cases.
The vigilance of the clinical mycologist must be maintained for a better 
understanding of how future changes can become serious public health problems, 
especially for yeasts, as we have already seen in several situations.
2. Ecology and sources of yeast infection
Yeasts can be found in plants, soil, air, aquatic environment, in invertebrate and 
vertebrate animals, that is, in almost all ecosystems. These microorganisms can be 
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can be part of their natural microbiota, in the gastrointestinal tract, in mucocutane-
ous tissues and skin. In man, a large part of yeast infections, especially of the genus 
Candida, are of endogenous origin and are linked to risk factors such as old age, 
prematurity, avitaminosis, antibiotic therapy, cancer, and other diseases that cause 
immunodepression of the host [7].
Extrinsic factors can also be important, such as the rupture of the natural bar-
rier of the skin and mucous membranes, the use of invasive hospital material and 
contact with contaminated ecological niches. Direct transmission between people 
can occur in sexual relations [8].
In dogs, the main yeast found on the skin and mucocutaneous surfaces is 
Malassezia pachydermatis, which easily recovers in the folds of the skin and espe-
cially in the various parts of the ear. The prevalence of some types of yeasts in the 
oral mucosa of dogs is related to several habits, such as licking, sniffing and explor-
ing environments.
The licking of the paws and other areas of the body explains the considerable 
presence of Malassezia pachydermatis in the oral cavity of dogs. Considered a 
saprophyte in the skin of dogs, this microorganism can cause dermatitis in several 
situations, and in these cases, there is also an increase in its presence in the oral 
mucosa. Other relevant yeasts of these animals belong to the genera Candida, 
Rhodotorula and Trichosporon, which are, in most cases, in balance with the dogs’ 
organism [9].
It is also reported that Cyniclomyces guttulatus, present in the stomach, intestine 
and feces, which in situations of imbalance with the commensal microbiota, may be 
related to clinical conditions that affect the gastrointestinal tract [10].
The habit of sniffing the soil, in parks and gardens, hunting in forests and dens, 
favors the sharing of microorganisms among animals linked to these environments. 
The organic matter present in these places, mainly in the feces of birds and bats, 
favors colonization by fungi such as Cryptococcus spp. and Histoplasma capsulatum, 
which in situations favorable to microorganisms (host immunosuppression; high 
microbial inoculum load) can cause serious diseases [11].
Advances in veterinary hospital techniques, especially surgical procedures and 
hospitalizations, also brings new sources of infection for dogs. The ability of micro-
organisms of the genera Candida and Malassezia to form biofilms makes equipment 
such as specula, probes and other surgical materials possible sources of transmis-
sion of these microorganisms. For this reason, the correct asepsis and sterilization 
for handling this equipment is extremely important to avoid mycoses and severe 
cases of fungemia [12].
3. Predisposing and virulence factors to yeast infections
There are several yeasts that are of interest to the veterinarian, which can 
cause superficial, subcutaneous, mucosal lesions, and even granulomatous and 
systemic processes, and, in most cases, suspicion about the fungal etiology of 
cases is neglected, hence advanced and severe cases of mycosis in dogs are not 
uncommon [13].
The transition from the yeast stage to commensal to pathogenic will depend  
both on factors related to the agent’s virulence, as well as on the host’s own  
susceptibility [14].
The factors that can predispose humans and animals to a yeast infection are 
innumerable, resulting from alterations in the defense mechanisms or by compro-
mising the anatomical barriers of protection of the organism [15–17].
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Among these factors we can mention: stress; use of broad-spectrum antibiotics  
or prolonged antibiotic therapy; antineoplastic agents; neutropenia; immunosup-
pression; age (senility/puppy); inadequate environment (overcrowding); long-term 
use of corticosteroids; nutritional deficiencies; diets with a high concentration 
of carbohydrates; pH changes, vitamin A deficiency, trichomoniasis; presence of 
autoimmune diseases; changes in anatomical barriers due to trauma (maceration); 
aplastic anemia; hematological infections; periodontal diseases (Figure 2) and 
other concomitant diseases [17, 18].
Prolonged antibiotic therapy and a high concentration of carbohydrates in the 
diet can lead to the destruction or inhibition of the competitive bacterial micro-
biota, disrupting its balance with the host organism, thus allowing the accentuated 
growth of yeasts [15].
Probably due to the poor oral hygiene of dogs throughout their life and associ-
ated with the other predisposing factors already mentioned, senility is considered a 
significant condition for predisposition to periodontal disease. Animals older than 
4 years, according to a study with stray dogs, are more likely to develop this disease, 
ranging from mild gingivitis to severe periodontitis (Figure 3).
Virulence factors attributed to microorganisms must also be taken into account, 
such as production of hydrolytic enzymes, proteases and phospholipases, adhe-
sion, formation of germ tube and biofilms. These factors favor the invasive power 
and interfere with the host’s metabolism. All these factors, from hosts and yeasts, 
can lead to superficial, or systemic, conditions. It is worth mentioning that the 
high concentration of viable cells of the microorganism in an ecological niche of 
the host is another factor that must be considered, as they may be part of the oral 
microbiota.
Figure 3. 
Connection: Age x Presence of Periodontal Disease in dogs [19].
Figure 2. 
Dog with periodontal disease.
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4. Importance of animals’ oral health
Disorders of the oral cavity are of great importance in veterinary medicine due 
to their high prevalence in dogs and their serious consequences, which can even 
affect the systemic health of the animal [20]. Abnormalities, injuries or disorders 
of this organ can cause discomfort and pain, leading the animal to anorexia, due 
to lack of food, and adipsia, not water intake, predisposing it to conditions of 
decreased immunity and clinical complications [21].
In addition to this great discomfort and the involvement of other organs, the 
inflammatory response caused by diseases in the oral cavity can lead to the gingival 
tissue a progressive loss of tooth fixation to the alveolar bone and, consequently, the 
loosening and loss of this tooth [22].
The dentistry specialty in veterinary medicine has been evolving in recent years, 
gaining space in the curriculum of some colleges. Even though the food industry 
has undergone great advances in the production of diets aimed at improving oral 
health, the number of professionals who perform an adequate clinical examination 
is still not significant. In addition to this important factor, the lack of adequate 
provision of oral hygiene care is worrying [22, 23].
Among dogs over one year of age, 95% have some degree of the disease, and in the 
clinic, it is believed that 100% of adult animals have varying degrees of periodontal 
disease [23]. The most common signs associated with periodontal disease are halitosis, 
dental calculus, inflammation and gingival bleeding, anorexia and the consequent 
weight loss, ptyalism, difficulty in chewing and grinding food, mobility and migra-
tion of teeth, loss of alveolar bone, gingival retraction and behavioral changes [24].
Periodontal disease is, therefore, the most common disease affecting dogs of all 
breeds, formed from proliferative microorganisms, defense cells (leukocytes and 
macrophages), epithelial cells, bacterial polysaccharides and salivary glycoproteins, 
which over time become organize, occurring mineralization and formation of 
dental calculus [25]. It is believed that this clinical condition is usually caused by 
the formation of bacterial plaques, but the isolation of yeasts from the oral cavity of 
dogs with periodontal disease is frequent (Figure 4).
The greatest risk in periodontopathic is not only the loss of teeth or the develop-
ment of local infections, but the possible systemic effects of the pathological agent 
in the bloodstream.
Thus, the oral health of dogs is extremely important and still needs a greater 
focus on microbiological research and awareness of those responsible, regarding 
food, the importance of oral hygiene, and the attention of the tutor and the veteri-
narian regarding the etiopathogenesis of diseases, such as yeasts.
Figure 4. 
Connection: Presence of Periodontal Disease x Positive isolation of yeast [19].
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5.  Main genera and species of yeasts isolated from the oral cavity of dogs 
and clinical signs
Just like in humans, dogs have a known range of yeasts in their oral mucosa that 
still requires more studies regarding colonization and pathogenicity. Despite its 
remarkable importance in the health of dogs, studies involving the isolation and 
correct identification of yeasts began to be developed in the 20th century [26].
This microbiota is not yet fully described, due to its great complexity and 
diversity. Fungal colonization of the oral cavity of dogs is associated with yeasts of 
the genera Candida, Malassezia, Trichosporon and Rhodotorula. Less frequently, we 
can isolate yeasts of the genus Cryptococcus [27].
In a recent study conducted with 50 mixed breed dogs, a yeast profile was 
found, composed of Candida albicans (39.5%), C. parapsilosis (18.6%), C. zeyl-
anoides (13.9%), C. krusei (7%), C. tropicalis (4.7%), Trichosporon spp. (4.7%),  
T. asahii (4.7%), C. guilliermondii (2.3%), T. mucoides (2.3%) and Malassezia 
pachydermatis (2.3%). The genus Candida showed a high prevalence, making 
up a total of 82.2% of the isolated yeast profile. It is worth mentioning here the 
isolation of Candida zeylanoides, a rare species, even in humans, and thus, the oral 
mucosa of dogs can harbor a new “ecological niche” of this fungus species, which 
can also act as an opportunistic pathogen [9].
5.1 Genus Candida and Candidiasis
Currently, 317 species of this genus are recognized. Several of these species, 
more precisely 20, have a pathogenic potential and can thus cause infections in 
several species of animals, such as dogs [17]. The relationship with the host can 
be commensal, parasitic or saprophytic. It can also be found in the usual form of 
a yeast, or in the form of pseudohyphae. Candida albicans is the most common 
colonizer in cases of infections, with a predilection for mucous surfaces and 
mucocutaneous areas. Other species, such as C. kefyr, C. lusitaniae, C. guilliermon-
dii, C. tropicalis, C. krusei, C. famata, C. parapsilosis, can be isolated from animals 
(Figure 5) [15].
There were only few cases found in the literature in small animals, however, 
reports of candidiasis in various animal species are also increasingly common, 
described in photos of pyoderma of the lip folds, disseminated and localized muco-
cutaneous dermatitis, urinary tract infections, gastrointestinal and reproductive 
system, ear infections, systemic and oral infections [27].
Figure 5. 
Presumptive result of Candida species isolated from the oral cavity of mixed breed dogs according to the 
CHROMAGAR Candida®.
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Candidiasis related to the digestive system of dogs, such as a clinical manifesta-
tion of glossitis, is characterized by the formation of pseudomembranous plaques, 
usually whitish in color, or yellowish beige. Once these plaques were removed, we 
noticed erythematous regions with the presence of ulcers (Figure 6) [28].
5.2 Genus Trichosporon and Trichosporonose
The genus Trichosporon has 37 species that inhabit different ecological niches, 
such as water, soil and body and mucous surfaces of humans and animals. They can 
cause superficial and deep infections, such as Trichosporon asahii, T. mucoides,  
T. ovoides, T. inkin, T. asteroides and T. cutaneum [29].
No cases of Trichosporon infections have been reported in the oral mucosa of 
dogs, however, several species have already been isolated as colonizers. Clinical 
cases of nasal granuloma in other animals, cystitis in cats, mastitis in cows and 
dermatitis in horses and monkeys have already been described (Figure 7) [30].
5.3 Genus Malassezia and Malasseziosis
The genus Malassezia has 15 species, mostly lipophilic yeasts, that can be part 
of the skin and mucous membranes of humans and dogs. They are opportunistic 
yeasts, and in certain circumstances, they can lead to clinical manifestations [31]. 
Malassezia pachydermatis, the most frequent in dogs, is not lipophilic and can grow 
in a culture medium common in mycology [19] (Figure 8).
Figure 6. 
Mixed breed dog with oral candidiasis (glossitis). Friable white and yellowish plates covering the tongue [28].
Figure 7. 
A and B –Yeasts of Genus Trichosporon showing oval and rectangular artrospores - (A) 160x and (B)  
400x [15].
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Several clinical symptoms can be associated with Malassezia spp. and, particu-
larly, in cases of otitis and dermatitis in dogs. Cases of otitis by Malassezia pachyder-
matis are frequency, but oral infection caused by this agent have not been described 
or has not yet been well studied [19].
5.4 Genus Cryptococcus and cryptococcosis
In the Cryptococcus genus, we found 38 species, with Cryptococcus neoformans 
and C. gattii being the most prominent in medical mycology in man and animals 
(Figure 9). The species can be found in different places in the environment, pri-
marily in association with birds’ droppings, mainly pigeons, but have an ecological 
association with trees too, such as eucalyptus [32].
In dogs, can enter the body through the lung causing pulmonary disease,  
and several clinical signs can be presented, such as skin lesions, nasal mucosa 
(“clown nose”), and can hit the central nervous system, for its neurotropic 
nature. These lesions in the nasal mucosa can extend into the oral cavity of the 
animals [28].
6. Collection of clinical material and identification of yeasts
6.1 Material collection
The collection of the oral cavity of dogs is performed with the aid of a sterile, 
alginate swab, moistened with sterile saline solution. The swab is introduced, 
Figure 9. 
Cryptococcus spp. Encapsulated yeasts - Nigrosina, 1000x.
Figure 8. 
Yeasts of the Genus Malassezia spp. - single budding on wide base - Panotic, 1000x.
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carefully, in the oral cavity, in circular movements, passing through the entire oral 
mucosa [19] (Figure 10).
After this procedure, the collected samples must be sent to the laboratory and 
sown in Petri dishescontaining basic mycology medium (Sabouraud dextrose agar), 
plus antibiotics (chloramphenicol - 0.05 g/L concentration). Incubation at 25°C for 
up to two weeks [19].
There are several procedures that can be used to identify yeasts. Direct examina-
tion (fresh), or with Gram stain is also highlighted (Figure 11).
6.2 Yeast identification
The identification of yeasts can be performed by means of macro and micro-
morphological, biochemical, proteome (MALDI-TOF) and molecular tests. 
In macromorphological characterization, we studied color, texture and edges 
(Figure 12).
In the more specific micro morphological identification, we must observe the 
characteristics of the cells (oval, round, unipolar bud, or multiple buds), pseudohy-
phae, hyphae and structures characteristic of C. albicans, such as chlamydoconidia 
(Figure 13).
The formation of a germ tube, another important characteristic of C. albicans, 
originates from blastoconidium when the yeast is sown in fetal bovine serum 
(Figure 14).
Figure 10. 
Collection with sterile swab of the oral mucosa of a mixed breed dog - City of Campinas, São Paulo - Brazil.
Figure 11. 
Yeasts of Genus Candida in an abdominal dog fluid sample - Fuchsin, 1000x.
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Tests of assimilation of sources of nitrogen and carbohydrates can be performed 
(auxanogram), as well as fermentation tests (zymogram). The protocol followed 
for these methods is from the manual “The Yeasts: a taxonomic study” (volumes 1, 
2 and 3). The MALDI-TOF technique is a mass spectrometry, which determines the 
protein profile (proteome) of the yeast under study. It is a fast technique (15–20), 
simple, excellent cost–benefit, however, there are limitations to the use of the labo-
ratory routine, as the device is expensive and requires specialists to use it, as well as 
a robust base of standard strains.
Figure 13. 
Candida albicans in culture broth. Globose, or elongated cells, pseudohyphae, hyphae, blastoconidia and 
characteristic chlamydoconidia, 1000x.
Figure 12. 
Culture of yeasts on Sabouraud dextrose agar.
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For the identification of yeasts, we also count on molecular biology tech-
niques, which are sensitive and specific. For the differentiation, for example, of 
C. albicans and C. dubliniensis is the most accurate technique. There are several 
methods such as PCR (Polymerase chain reaction), RFLP (Restriction fragment 
length polymorphism) and RAPD (Random amplified polymorphic DNA). One 
of the most used is PCR, which detects minimal amounts of DNA, or RNA. But 
not all laboratories can use these methods, due to the higher costs and the needs of 
specialized laboratories [33].
Figure 14. 
Germ tube on bovine serum – Candida albicans, 400x.
Figure 15. 
Yeasts of genus Candida on CHROMAGAR Candida® - Candida albicans with green color.
Figure 16. 
API20CAUX method (bioMérieux®) –profile of carbohydrates assimilation.
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6.3 Chromogenic medium: CHROMagarCandida®
Sowing in chromogenic media, such as CHROMagarCandida®, can provide 
presumptive identification according to the color developed by the yeast. In this 
medium, the specie Candida albicans develops a light green color; C. tropicalis it is 
blue/green and C. krusei light pink, for example (Figure 15).
In addition to these identification methods, there are several automated and 
manual systems that facilitate the laboratory routine, such as Vitek and API20C, as 
examples (Figure 16).
7. Epidemiological markers
As we have already pointed out, yeasts (especially those of the genus Candida) 
have emerged as important pathogens in humans and animals and the interrelation 
between both is of great relevance, gaining prominence today.
Several markers can be used to detect new yeast species as well as their genotype. 
Based on the data, we can determine the presence of these microorganisms, the 
same species/genotype, in one or more anatomical areas of the host, as well as of 
different ecological niches.
Confirming the colonization/infection area has often been an arduous task. 
Therefore, the use of these markers shows to be of great importance for the epide-
miological study of yeasts.
Among the phenotypic markers, we can highlight those based on colony 
morphology (morphotyping), enzyme production (enzyme typing),  sensitivity 
to “Killer” toxins and antifungal agents. They are simple and easy to perform 
techniques.
Genotypic markers are more sophisticated and safer; however, they require more 
elaborate techniques. The technique is based on short sequential repetition of bases 
throughout the yeast genome and its reading is performed on a specific sequencing 
apparatus. The patterns of the visualized DNA bands function as true “fingerprints” 
of the microorganism, leading us to the recognition of the colonization/infection 
area of the host. This technique can be used both for use in clinical isolates and for 
environmental samples (Figure 17).
With increasingly interconnected ties between man and his dog, the use of these 
markers is a valuable technique for detecting epidemiological transmission between 
Figure 17. 
Chromosomal bands of yeasts obtained by electrophoresis pulsed field - PFGE.
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these species and a facilitator for taking therapeutic actions based on the microbio-
logical analysis of the agent’s transmitter [33].
8. Antifungals, sensitivity tests and treatment
Currently, yeast mycoses have increased substantially, and it can be considered 
an important public health problem, especially in systemic clinical conditions and 
hospital infections. The antifungal drugs used in human and veterinary medicine 
have special characteristics regarding the chemical structure and the mechanism 
of action, interfering directly or indirectly in the fungal cell, with fungistatic or 
fungicidal actions [34].
Among the existing antifungal drugs, the most widely used and known are 
polyenic, imidazolic, pyrimidine, sulfamide, benzofurenic and other compounds 
with varying degrees of success, such as iodides, thiosulfates, sulfides and 
tolnaftates. In the treatment of invasive fungal infections, classes of polyene 
antifungals (amphotericin B), azoles (fluconazole, voriconazole, ketoconazole, 
itraconazole, posaconazole), pyrimidines (5-fluorocytosine) and echinocandin, 
caspofungin, micafungin) are mainly used [35]. The increasing incidence of 
yeast infections, such as those present in the oral mucosa, has been a target of 
constant concern in the search for increasingly effective treatments and safer 
drugs. The use in the treatment and prophylaxis of antifungals such as fewer 
toxic azoles, especially fluconazole, has given rise to cases of resistance among 
susceptible yeast species.
The resistance of fungi to antifungal agents can be classified into clinical and 
microbiological resistance. The concept of clinical resistance is defined when there is 
a persistence or progression of a fungal infection even with the administration of the 
drug chosen as appropriate. In this case, “in vitro” tests may indicate the sensitivity 
of the agent to the antifungal. Usually, the occurrence of clinical resistance is associ-
ated with host, iatrogenic, pharmacological factors and factors related to the fungus 
virulence [36]. Microbiological resistance is a phenomenon in which the etiologic 
agent can develop in the presence of therapeutic concentrations of antifungals, a 
capacity verified “in vitro”. Resistance can be intrinsic, primary or secondary, or 
extrinsic. This aspect is of real importance since we are increasingly faced with resis-
tant yeasts, especially the “critical” species, highlighting C. auris and C. haemulori, 
whose findings should be immediately reported to the treatment team.
Intrinsic resistance is so called when no member of a species is sensitive to the 
antifungal, being primary, when in a species normally sensitive to an antifungal 
we find a resistant strain (without exposure to it) or secondary or acquired, when 
a previously sensitive strain develops resistance after exposure to a drug, due to 
phenotypic or genotypic changes [37]. The mechanism of resistance to antifungals 
by fungi, both for clinical or microbiological resistance, is involved with cellular, 
biochemical and/or molecular responses.
In the cellular mechanism, strains or sensitive specimens are exchanged for 
resistant endogenous ones, genetic alteration, a fact that guarantees secondary 
resistance, transient genetic expression and alteration in the cell type. Regarding 
the biochemical mechanism, phenotypic changes in fungi occur, allowing the 
absorption of the drug to be slower, altering the target site and increasing the excre-
tion of the drug. The changes from the molecular point of view causing a genetic 
amplification to occur, mutations, among other modifications in the gene involved 
in the defense against the antifungal. In addition to these changes, another molecu-
lar alternative of resistance is the ability to form biofilms, an efficient physical 
barrier [36].
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The greater phenotypic variability of Candida species, for example, together 
with the increased resistance of strains to antifungals, has assumed a prominent 
role as a clinical problem [9]. The different species of this yeast vary in sensitivity to 
antifungals on the market, a fact that shows the great importance of identifying and 
determining the minimum inhibitory concentration (MIC) [38].
Due to this aspect, the development of standardized methods of sensitivity “in 
vitro” is of vital importance and serve as guide to indicate the therapeutic choice, 
monitor the effectiveness of the antifungal and decrease the formation of resistant 
strains [39]. The appropriate choice of antifungal agent is, therefore, decisive in the 
therapeutic response of the animal. To this end, research that aims at determining 
the antifungal profile of the main yeasts isolated from dogs is of great therapeutic 
value [9].
The most used parameter for determining sensitivity to antifungals is the 
minimum inhibitory concentration (MIC), defined as the lowest concentration 
of an antifungal agent that inhibits the growth of the fungus [40]. From the MIC 
value, the yeast sample is classified according to the breakpoints established by 
international committees, which allows the fungus to be characterized as sensitive, 
intermediate, dose-dependent and resistant sensitivity [38]. For the detection of 
sensitivity/resistance to antifungals, highlight of use in therapeutic failures, we can 
count on several techniques, being “Gold standard” the method recommended by 
CLSI, the microdilution test.
The determination of the sensitivity of a fungus to antifungals can also be 
determined by commercial methods compatible with the tests recommended 
by CLSI [17, 37]. Sensitivity tests using a solid medium, such as the commercial 
method “E-test”, are of real interest in several studies and in the laboratory rou-
tine. It is an excellent technique for determining the sensitivity to antifungals “in 
vitro”, simple, easy to perform, with fast results, without the need for expensive 
or specialized equipment [41]. “E-test” is based on a combination of dilution and 
diffusion test concepts that directly quantify antifungal sensitivity. It consists of 
tapes containing pre-established concentrations of the antifungal agent, which 
are placed in a solid medium and with the yeast sample. When the tape is applied 
to the plate, immediate drug release occurs, thus the MIC is determined by the 
intersection of the inhibitory hyperbole formed by the growth of yeast in the 
plate (Figure 18).
Because the MIC values of “E-test” are directly proportional to the values 
referenced by the dilution CLSI, this method has a good correlation with this test. 
However, it may still present differences inherent to the process.
Figure 18. 
“E-test” commercial method. MIC is determined by the intersection of the inhibitory area formed by yeast 
growth.
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The classification by this method determines the isolate as sensitive, dose-
dependent and resistant (Table 1).
For tests to determine the antifungal profile, source control strains of the 
“American Type Culture Collection” (ATCC) are always used under identification, 
such as, for example, ATCC64548 (C. albicans) and ATCC777 (C. dubliniensis).
In the treatment of invasive fungal infections, classes of polyene antifungals 
(amphotericin B), azoles (fluconazole, voriconazole, ketoconazole, itraconazole, 
posaconazole), pyrimidines (5-fluorocytosine) and echinocandin, (caspofungin, 
caspofungin, micafungin) are mainly used [35].
For the systemic treatment of yeasts, we can use Amphotericin B, in the most 
varied forms (liposomal, suspension of lipid complexes). Nystatin can be used 
orally or in suspension, ointments and creams (as for example, in cases of oral can-
didiasis). In animals, the use of each of these antifungals is quite varied and their 
recommendation and dose will depend a lot on the etiological agent in question and 
the side effects that can be generated.
When analyzing the profile of sensitivity to antifungals compared to isolates from 
the oral cavity of dogs (mucosa that has greater transmissibility to humans), the 
best active antifungals found in the veterinary are ketoconazole and voriconazole. 
Ketoconazole is still widely used in clinics and pet shops, mainly, topically. For the 
treatment of candidiasis in small animal clinics, ketoconazole is one of the most 
frequently used drugs, as it has a broad spectrum of activity, encompassing several 
species of Candida spp. and dermatophytes. From isolates from the oral cavity 
of dogs it shows high sensitivity between yeasts and has several presentations for 
veterinary use, representing an economically viable alternative, however, due to its 
toxicity, the trend is disuse [9, 17].
Voriconazole has a broad spectrum of activity and a potent “in vitro” action. 
Its mechanism of action is like other azole antifungals, inhibiting the enzyme 14 
alpha-demethylase, dependent on cytochrome P-450, essential for the ergosterol 
biosynthesis. It can be indicated as a good alternative to replace ketoconazole, 
however its cost is high. This drug is also used for the treatment of systemic 
mycoses, mainly in candidiasis, aspergillosis and cryptococcosis in debilitated, 
immunosuppressed patients or in cases of resistance to another antifungal [43]. The 
antifungals fluconazole, itraconazole and miconazole are also routinely applied in 
the veterinary clinic, used indiscriminately in the treatment of mycosis suggestively 
diagnosed. However, resistance to these drugs has increased, so their use should be 
more cautious.
Candida zeylanoides, for example, is a relatively rare yeast in humans and 
animals. In humans it has been reported from skin, nails and blood isolation, 
considered an opportunistic pathogen, also involved in cases of endocarditis in an 
Antifungals S (μg/mL) SDD (μg/mL) R (μg/mL)
Miconazol* ˂ 8 8–16 ≥ 16
Cetoconazol ˂ 16 — ≥ 16
Fluconazol ≤ 8 16–32 ≥ 64
Itraconazol ˂ 0,25 0.25–0.5 ≥ 1
Voriconazol ≤ 1 2 ≥ 4
Caspofungina ≤ 2 — ˃ 2
S: sensitive; SDD: dose dependent sensitivity; R: resistant; NS: not sensitive [38, 42].
Table 1. 
Interpretation of the behavior of yeast strains against the concentration of antifungals (μg/ml).
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HIV-positive patient [44]. Samples of this yeast were isolated for the first time in the 
oral cavity of stray dogs and demonstrated significant resistance to the antifungal 
fluconazole. In addition to this species, Candida krusei also obtained partial results 
of resistance to this antifungal, as well as yeasts of the genus Trichosporon spp. [9].
Itraconazole is a synthetic triazole derivative with a wide spectrum of action, 
widely used in the treatment of superficial mycoses by candidiasis, malasseziosis and in 
systemic mycoses. When used orally right after a meal, its bioavailability is maximum, 
with biphasic elimination. This antifungal has also been used successfully in dogs with 
mycotic rhinitis and in systemic mycoses, such as blastomycosis. However, its use in 
dogs can lead to skin rashes and, in high dosages, it can cause anorexia and increased 
plasma concentration of alkaline phosphatase and aminotransferase enzymes [43].
In addition, species isolated from the oral cavity of dogs (especially Candida albi-
cans and C. tropicalis) have shown dose-dependent sensitivity to itraconazole. Yeasts 
of the genus Trichosporon also isolated from this active site, show medium resistance to 
fluconazole and significant resistance to itraconazole, which reveals concern about the 
use of these drugs in the treatment of candidiasis and triconosporoses in dogs [9, 19].
In the veterinary medical clinic, miconazole is commonly indicated for the 
treatment of dermatophytosis, malasseziosis and candidiasis. However, yeasts of 
the genus Trichosporon and Malassezia pachydermatis isolated from the oral cavity of 
dogs show important resistance to this antifungal. Different for Candida yeasts, in 
which the antifungal profile demonstrates sensitivity to miconazole [9, 19].
Caspofungin is an antifungal with an inhibitory action on the cell wall of the 
echinocandin group, important in human medicine as an alternative for the treat-
ment of isolates resistant to fluconazole [45]. Against yeasts isolated from the 
oral cavity of dogs, yeasts of the genus Trichosporon and of the genus Malassezia 
 demonstrate significant resistance to this antifungal, resistance also demonstrated 
to a lesser extent by the species Candida parapsilosis [9, 19].
In cases of systemic infections, affecting different species of animals, the use of 
amphotericin B, a drug that acts on the fungal cell membrane, has efficiency against 
strains of Candida spp. However, due to the high cost and serious side effects, such 
as hepatotoxicity, nephrotoxicity, myelotoxicity and cardiotoxicity, this medication 
is seldom used [17].
Due to the great similarity between the fungal cell and the host cell, the action 
of antifungals presents relatively high toxicity. Thus, there is a need for research for 
the best choice of antifungal, based on the most appropriate therapeutic response 
and on the sensitivity profile of yeast against antifungal floodgates, seeking as 
well to minimize the side effects that can be generated with the use of more drugs 
needed in cases of therapeutic failure [43].
When information is obtained that a street animal, which in general is a dog 
that, has never received therapeutic treatment based on antifungal, presents 
positive isolation for resistant yeasts, it is assumed that environmental yeasts are 
undergoing an important primary resistance or that the ecological niche in which 
that animal lives is contaminated by resistant microorganisms originating from 
direct or indirect human contamination.
Corroborating this fact, we must consider the excessive use of pesticides in the 
environment and mycoherbicides (placed in plantations, vegetable gardens, and in the 
soil itself), have a chemical constitution like azoles, thus representing a strong selec-
tive pressure for the emergence of strains resistant. This question of possible envi-
ronmental contamination and fungal resistance is already discussed for other yeast 
species, such as Cryptococcus spp. and medical mycology becomes an important issue.
The growing data on increased resistance of fungi against antifungal drugs have 
been causing great concern for human and veterinary doctors. Although data on 
resistance to antifungals from yeasts isolated from dogs are scarce, their importance 
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is notorious, directly associated with the therapeutic success of these animals 
particularly important for society and human health (physical and mental).
Therefore, the ideal therapeutic choice, for both humans and animals, should be 
based on prior identification of the agent and, if possible, the use of techniques for 
determining the sensitivity profile of the etiologic agent against antifungals.
9. Considerations
The oral cavity is an extremely important anatomical area of dogs, considered as 
one of the determining factors in the longevity of this animal’s life. To reduce thera-
peutic failures and guarantee the perfect health condition of this system, knowledge 
of the existing microbiota is essential, but it is still scarce.
We can then ask ourselves: Why are recurrent fungal infections more and more 
frequent in dogs? What is the relationship between the microbiota of dogs and their 
respective owners? And what is the relationship of resistance to fungal infections 
between these species?
Possible answer to these questions could be founded in this chapter, as well as 
the beginning of the knowledge of the main yeasts found in the oral cavity of dogs, 
their clinical importance and profile of resistance to the main antifungals used in 
the practical routine of veterinary medicine.
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